Eloxx Pharmaceuticals, Inc.

ELOX · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$36-$67-$35-$51
Dep. & Amort.$1$1$1$1
Deferred Tax$0-$0$0-$0
Stock-Based Comp.$3$9$9$11
Change in WC-$0-$0-$3-$1
Other Non-Cash$1$22$1$1
Operating Cash Flow-$32-$35-$28-$39
Investing Activities
PP&E Inv.-$0-$0$0-$0
Net Acquisitions$0$2$0$0
Inv. Purchases$0$0$0-$67
Inv. Sales/Matur.$0$0$34$34
Other Inv. Act.$0$0$0-$0
Investing Cash Flow-$0$2$34-$34
Financing Activities
Debt Repay.$0$0-$4$15
Stock Issued$0$48$0$33
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$9$3$0-$1
Financing Cash Flow$9$51-$3$47
Forex Effect$0$0$0$0
Net Chg. in Cash-$23$18$2-$26
Supplemental Information
Beg. Cash$43$25$23$49
End Cash$19$43$25$23
Free Cash Flow-$32-$35-$28-$39
Eloxx Pharmaceuticals, Inc. (ELOX) Financial Statements & Key Stats | AlphaPilot